Effects of Respiratory Exchange Ratio on the Prognostic Value of Peak Oxygen Consumption and Ventilatory Efficiency in Patients with Systolic Heart Failure
Overview
Authors
Affiliations
Objectives: The purpose of this analysis was to evaluate the prognostic characteristics of peak oxygen consumption (Vo2) and the minute ventilation/carbon dioxide (VE/Vco2) slope of different peak respiratory exchange ratios (RERs) obtained from cardiopulmonary exercise testing in patients with heart failure (HF).
Background: For patients with HF, peak Vo2 and the VE/Vco2 slope are used for assessing prognosis. Peak Vo2 is assessed in association with peak RER ≥1.10, indicating maximal effort and prognostic sensitivity. Conversely, the VE/Vco2 slope provides effort-independent prognostic discrimination.
Methods: Patients with HF scheduled to undergo cardiopulmonary exercise testing were enrolled. Patients were subclassified by peak RER (RER <1.00, RER 1.00 to 1.04, RER 1.05 to 1.09, RER ≥1.10) and followed for up to 3 years for major cardiac-related events (death, left ventricular assist device implantation, or cardiac transplantation).
Results: Included were 1,728 patients with HF (75% males; 40% ischemic etiology; age: 55 ± 14 years; left ventricular ejection fraction: 28 ± 10%). Two hundred seventy major events occurred, with no proportional differences across the RER subgroups. Multivariate Cox regression analysis indicated that the VE/Vco2 slope and peak Vo2 remained prognostic within each subgroup; the VE/Vco2 slope remained the strongest predictor. Receiver-operating characteristic analysis demonstrated equitable prognostic cutoffs for the VE/Vco2 slope (range: 34.9 to 35.7; area under the curve [AUC] range: 0.69 to 0.75) and peak Vo2 (range: 13.8 to 14.0 ml·kg(-1)·min(-1); AUC range: 0.68 to 0.75).
Conclusions: Peak Vo2 provided a sensitive assessment of prognosis in patients with HF in all RER subgroups. The VE/Vco2 slope provided greater prognostic discrimination in all RER subgroups. Clinical consideration may be warranted for patients with low RER, low peak Vo2, and an elevated VE/Vco2 slope.
Lyu L, Wang X, Xu J, Liu Z, He Y, Zhu W Cardiovasc Diabetol. 2024; 23(1):162.
PMID: 38724999 PMC: 11080126. DOI: 10.1186/s12933-024-02213-2.
Lai P, Xue J, Xie M, Ye J, Yang N, Zhong Y Medicine (Baltimore). 2023; 102(8):e33010.
PMID: 36827059 PMC: 11309679. DOI: 10.1097/MD.0000000000033010.
Does recovery from submaximal exercise predict response to cardiac resynchronisation therapy?.
Wouters P, Schoots T, Niemeijer V, Spee R, Kemps H Open Heart. 2022; 9(2).
PMID: 36376007 PMC: 9664270. DOI: 10.1136/openhrt-2022-002047.
Mazur A, Brat K, Homolka P, Merta Z, Svoboda M, Bratova M PLoS One. 2022; 17(8):e0272984.
PMID: 35960723 PMC: 9374210. DOI: 10.1371/journal.pone.0272984.
The Obesity Paradox in Chronic Heart Disease and Chronic Obstructive Pulmonary Disease.
Giri Ravindran S, Saha D, Iqbal I, Jhaveri S, Avanthika C, Naagendran M Cureus. 2022; 14(6):e25674.
PMID: 35812616 PMC: 9259072. DOI: 10.7759/cureus.25674.